Monitor for symptoms of high estrogen including water retention, sensitive nipples, or mood changes
Potential side effects observed during clinical research include mild nausea, vomiting, diarrhea, and constipation
In addition to aforementioned properties of GLP-1 agonists, it can also reduce hypertension by activating and phosphorylating endothelial nitric oxide synthase pathways, thus increasing the bioavailability of nitric oxide which promotes vasodilation
And dysesthesia is essentially a retatrutide-specific phenomenon that has no meaningful equivalent in tirzepatide therapy
As your dose increases, many people report stronger appetite suppression and greater weight loss momentum
Both medications remain investigational and are not yet FDA approved